Suppr超能文献

[脾肿大超过1000克的脾切除术。36例患者的回顾性研究]

[Splenectomy for splenomegaly of more than 1000 grams. A retrospective study of 36 patients].

作者信息

Glehen O, Caillot J L, François Y, Peyrat P, Sadeghi Loyeeh B, Griot J B, Gilly F N, Vignal J

机构信息

Laboratoire de Recherche Hyperthermie-Oncologie, Faculté de Médecine Lyon Sud, Oullins.

出版信息

Ann Chir. 1997;51(10):1099-105.

Abstract

Splenectomy for massive splenomegaly is frequently performed for hematologic disorders for diagnostic and therapeutic indications. The role of splenectomy is complex and controversial. The aims of our retrospective study were to focus on postoperative complications and advantages of splenectomy for massive splenomegaly. Thirty six patients with splenomegaly weighing 1000 g or more, underwent splenectomy at Centre Hospitalier Universitaire Lyon Sud, from January 1st, 1982, to December 31, 1995. Thirty-one (85%) of these patients had hematologic malignancy and more than half of them were older than sixty years. The main indications for splenectomy were hypersplenism (18 patients) and diagnosis (14). Preliminary ligation of the splenic artery was performed in 25 patients (42%). All patients had drainage. The mortality and morbidity rates were 5.5% and 20%, respectively. No major septic or thromboembolic complications occurred. There was only one major bleeding complication. The advantages of splenectomy included histopathological diagnosis in 13 of 14 patients with splenomegaly of unknown origin, permanent pain relief in all cases, and immediate correction of hematological cytopenia in 27 cases (75%). We conclude that the large weight of the spleen does not constitute a contraindication to splenectomy, but indications must be carefully selected, and the operative and perioperative management, must be appropriate.

摘要

因巨大脾肿大而行脾切除术常用于治疗血液系统疾病,具有诊断和治疗双重目的。脾切除术的作用复杂且存在争议。我们这项回顾性研究的目的是聚焦于巨大脾肿大患者行脾切除术后的并发症及优势。1982年1月1日至1995年12月31日期间,36例脾脏重量达1000克及以上的脾肿大患者在里昂南大学医院接受了脾切除术。其中31例(85%)患者患有血液系统恶性肿瘤,且半数以上患者年龄超过60岁。脾切除术的主要指征为脾功能亢进(18例)和诊断需要(14例)。25例(42%)患者进行了脾动脉的预先结扎。所有患者均有引流。死亡率和发病率分别为5.5%和20%。未发生严重的感染或血栓栓塞并发症。仅出现1例严重出血并发症。脾切除术的优势包括:14例病因不明的脾肿大患者中有13例获得了组织病理学诊断;所有病例均实现了永久性疼痛缓解;27例(75%)患者的血细胞减少症得到了即刻纠正。我们得出结论,脾脏重量大并不构成脾切除术的禁忌证,但必须仔细选择手术指征,且手术及围手术期管理必须恰当。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验